Pharma Co. Misled Investors On Research Methods, Suit Says
Pharmaceutical company Anavex has been hit with a proposed shareholder class action alleging that it misled the public about research methodologies it was using in its clinical studies for neurological treatments....To view the full article, register now.
Already a subscriber? Click here to view full article